Cancer incidence and mortality in France over the 1980???2012 period: Solid tumors, Revue d'??pid??miologie et de Sant?? Publique, vol.62, issue.2, pp.95-108, 2014. ,
DOI : 10.1016/j.respe.2013.11.073
Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2015, 2015. ,
Global surveillance of cancer survival 1995???2009: analysis of individual data for 25???676???887 patients from 279 population-based registries in 67 countries (CONCORD-2), The Lancet, vol.385, issue.9972, pp.977-1010, 2015. ,
DOI : 10.1016/S0140-6736(14)62038-9
Cancer survival in Europe 1999???2007 by country and age: results of EUROCARE-5???a population-based study, The Lancet Oncology, vol.15, issue.1, pp.23-34, 2014. ,
DOI : 10.1016/S1470-2045(13)70546-1
Ten year results of conservative surgery and irradiation for stage I and II breast cancer, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.2, pp.269-77, 1991. ,
DOI : 10.1016/0360-3016(91)90771-U
Screening for recurrent breast cancer--its effectiveness and prognostic value., Journal of Clinical Oncology, vol.5, issue.1, pp.62-69, 1987. ,
DOI : 10.1200/JCO.1987.5.1.62
Recommandations pour le Plan Cancer Pour un nouvel élan, 2009. ,
portant réforme de l'hôpital et relative aux patients, à la santé et aux territoires, 2009. ,
Recommandations pour le troisième plan cancer, 2013. ,
Future Supply and Demand for Oncologists : Challenges to Assuring Access to Oncology Services, Journal of Oncology Practice, vol.3, issue.2, pp.79-86, 2007. ,
DOI : 10.1200/JOP.0723601
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793740
Cancer Care and Survivorship Planning: Promises and Challenges, Journal of Oncology Practice, vol.5, issue.3, pp.116-124, 2009. ,
DOI : 10.1200/JOP.0934407
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790677/pdf
Discharge of breast cancer patients to primary care at the end of hospital follow-up: A cross-sectional survey, European Journal of Cancer, vol.49, issue.8, pp.1836-1880, 2013. ,
DOI : 10.1016/j.ejca.2013.01.016
Views of primary care providers on follow-up care of cancer patients, Fam Med, vol.39, pp.477-82, 2007. ,
Are primary care providers prepared to care for survivors of breast cancer in the safety net? Cancer. 15 avr 2015, pp.1249-56 ,
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002, International Journal of Cancer, vol.106, issue.Suppl. 6, pp.2404-2416, 2000. ,
DOI : 10.1002/ijc.11226
Breast Cancer Follow-Up and Management After Primary Treatment, Clinical Oncology Clinical Practice Guideline Update. JCO. 1 mars, vol.31, issue.7, pp.961-966, 2013. ,
Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update), Canadian Medical Association Journal, vol.172, issue.10, pp.1319-1339, 2005. ,
DOI : 10.1503/cmaj.045062
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.26, issue.suppl 5, pp.8-30, 2015. ,
DOI : 10.1093/annonc/mdv298
Recommandations pour la prise en charge des carcinomes canalaires in situ du sein. Institut National Contre le Cancer, pp.9-20, 2009. ,
Follow-up strategies for women treated for early breast cancer, Cochrane Database Syst Rev, vol.4, issue.4, p.1768, 2005. ,
DOI : 10.1007/BF01806043
URL : http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001768.pub2/pdf/abstract
Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience, British Journal of Cancer, vol.2, issue.12, pp.1802-1809, 2007. ,
DOI : 10.1016/0360-3016(89)90003-5
Shared responsibility for follow-up of breast cancer patients. Experience of the Institut Curie, Bull Cancer, vol.95, pp.1047-51, 2008. ,
Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract, pp.60-65, 1995. ,
Routine follow up of breast cancer in primary care: randomised trial, BMJ, vol.313, issue.7058, pp.665-674, 1996. ,
DOI : 10.1136/bmj.313.7058.665
Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care, Journal of Clinical Oncology, vol.24, issue.6, pp.835-842, 2006. ,
DOI : 10.1200/JCO.2005.04.5153
Comparison of breast cancer patient satisfaction with follow-up in primary care vs specialist care: results from a randomized controled trial, Br J Clin Pract, vol.49, pp.705-715, 1996. ,
Breast cancer followup by primary care physician: patient satisfaction in the Metropolitan Paris region], Bull Cancer, vol.99, issue.10, pp.915-940, 2012. ,
Survivorship care in breast cancer, Les soins aux survivantes du cancer du sein, Canadian Family Physician. 1 juin, vol.61, issue.6, pp.277-83, 2015. ,
Patients' preferences for post-treatment breast cancer follow-up in primary care vs. secondary care: a qualitative study, Health Expectations, vol.12, issue.Suppl. 2, pp.2192-201, 2015. ,
DOI : 10.1080/13645570701606028
URL : http://onlinelibrary.wiley.com/doi/10.1111/hex.12189/pdf
A pilot study exploring the effect of discharging cancer survivors from hospital follow-up on the workload of general practitioners, Br J Gen Pract J R Coll Gen Pract, vol.48, issue.430, pp.1241-1244, 1998. ,
Etude sur le suivi par les médecins généralistes des femmes traitées pour un cancer du sein. Enquête auprès de 282 médecins généralistes d'Aquitaine. Doctorat de médecine générale, Bordeaux: université Bordeaux, vol.2, 2015. ,
Clinicians' attitudes to clinical practice guidelines : a systematic review-attitudes-clinical-practice-guidelines-systematic- review, Disponible sur, 2002. ,
Follow-up in patients with early breast cancer, Bull Cancer. oct, vol.98, issue.9, pp.1091-106, 2011. ,
Infos cancer du sein, Disponible sur, 2017. ,
La surveillance du cancer du sein. [en ligne]. [consulté le 28 Disponible sur : http://www.canceraquitaine.org/sites/default/files/documents/INFOS- PRO/surveillance-sein, 2017. ,
Le cancer du sein. [en ligne]. [consulté le 28 Disponible sur : https://www.ligue-cancer, 2017. ,
Les cancers du sein. [en ligne]. [consulté le 28, Disponible sur, 2017. ,
Après cancer. [en ligne]. [consulté le 28, Disponible sur, 2017. ,
Guidelines in professions allied to medicine, Cochrane Review, vol.1, issue.2, 2002. ,
DOI : 10.7326/0003-4819-100-1-130
Medical Practice Guidelines: Current Activities and Future Directions, Annals of Internal Medicine, vol.113, issue.9, pp.709-714, 1990. ,
DOI : 10.7326/0003-4819-113-9-709
Barriers to GPs' use of evidence-based medicine: a systematic review, British Journal of General Practice, vol.62, issue.600, pp.511-532, 2012. ,
DOI : 10.3399/bjgp12X652382
Thou shalt versus thou shalt not: a meta-synthesis of GPs' attitudes to clinical practice guidelines, British Journal of General Practice, vol.57, issue.545, pp.971-979, 2007. ,
DOI : 10.3399/096016407782604820
A comprehensive framework and key guideline recommendations for the provision of evidence-based breast cancer survivorship care within the primary care setting, Family Practice, vol.32, issue.2, pp.129-169, 2015. ,
DOI : 10.1093/fampra/cmu082
Atlas de la démographie médicale en France, 2015. ,
Detection of local recurrence after conservative therapy for breast carcinoma.Cancer, pp.493-499, 1992. ,
Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment, International Journal of Radiation Oncology*Biology*Physics, vol.19, issue.4, pp.833-875, 1990. ,
DOI : 10.1016/0360-3016(90)90002-2
Amalric Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis.Cancer, pp.1912-1919, 1989. ,
Risk of second cancers cancer after a first primary breast cancer: A systematic review and meta-analysis, Gynecologic Oncology, vol.136, issue.1, pp.2015158-71 ,
DOI : 10.1016/j.ygyno.2014.10.029
Prognostic significance of mammographic detection in a cohort of conservatively treated breast cancer patients, Cancer J Sci Am, vol.4, pp.35-40, 1998. ,
Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial, JAMA, vol.271, pp.1587-92, 1994. ,
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, The Lancet, vol.381, issue.9869, pp.805-821, 2013. ,
DOI : 10.1016/S0140-6736(12)61963-1
Comparisons between different polychemotherapy regimens for early breast cancer : metaanalyses of long-term outcome among 100,000 women in 123 randomised trials, Lancet. 2012 Feb, vol.4379, issue.9814, pp.432-476 ,
Adjuvant Endocrine Therapy for Women With Hormone Receptor???Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update, Journal of Clinical Oncology, vol.32, issue.21, pp.2255-69, 2014. ,
DOI : 10.1200/JCO.2013.54.2258
From best evidence to best practice: effective implementation of change in patients' care, The Lancet, vol.362, issue.9391, pp.1225-1255, 2003. ,
DOI : 10.1016/S0140-6736(03)14546-1
Changing Physicians' Practices, New England Journal of Medicine, vol.329, issue.17, pp.1271-1275, 1993. ,
DOI : 10.1056/NEJM199310213291714
Effectiveness and efficiency of guideline dissemination and implementation strategies, Health Technol Assess, vol.8, pp.1-72, 2004. ,
Effectiveness of clinical guideline implementation strategies : systematic review of systematic reviews, Gastroenterol Clin Biol. nov, vol.24, issue.11, pp.1018-1043, 2000. ,
Pourquoi les médecins généralistes n'observent-ils pas les recommandations de bonnes pratiques cliniques ? L'exemple du diabète de type 2, Sciences sociales et santé. 1 juin, vol.24, issue.2, pp.75-103, 2006. ,
DOI : 10.3406/sosan.2006.1681
URL : http://www.persee.fr/docAsPDF/sosan_0294-0337_2006_num_24_2_1681.pdf
aidea-ligue.net) Conseils juridiques et accompagnement pour le droit à l'emprunt, pp.111-101 ,
information : Espaces Cancer Info Centre d'oncologie et de radiothérapie du Pays Basque -Service de radiothérapie 14 allées Paulmy -64100 Bayonne Tél, pp.5-59 ,
André : lundi, mardi 10h-17h Pellegrin -Centre FX Michelet : mercredi 9h-13h Pellegrin -Tripode : mercredi 14h-16h Maison du Haut- Lévêque : jeudi 10h-17h, vendredi 9h-16h Tél. : 05 57 82 01 97, mail : eri@chubordeaux.fr ? Institut Bergonié : 229 cours de l'Argonne -33076 Bordeaux Cedex Tél, 05 56 33 33 54, mail : l.innocenti@bordeaux.unicancer.fr Kiosques d'Information sur le Cancer (KIC) ? Maison du Bien-Être -Centre de santé du Pavillon de la Mutualité 45 cours Galliéni - 33000 Bordeaux Tél. : 06 67 60 92 22, mail : instantdebeaute@hotmail.fr ? Maison de la Ligue Bayonne Espace Rive Gauche -66 allées Marines -64100, pp.5-59 ,
AROMASINE) prévoir une ostéodensitométrie à l'initiation du traitement, à renouveler tous les 2 ans si elle est altérée après avoir débuté un traitement ,
Herceptine est administré (tumeur Her2+; 10 % des cas) une surveillance de la fonction cardiaque tous les 3 mois est alors nécessaire le temps du traitement ( = 1 an ,
il existe un risque de lymphoedème du bras qui nécessite quelques précautions : pas de prise de tension ou de prise de sang du côté opéré ,
on peut noter : -des troubles cognitifs fréquents (trouble de mémoire) qui régresseront dans l'année qui suit le traitement ,
un épisode dépressif réactionnel est fréquent surtout à 2-3 mois de la fin de la radiothérapie. Si des anti dépresseurs sont nécessaires on rappelle que la fluoxétine (PROZAC) ou la paroxétine (DEROXAT) ,